Methotrexate (MTX) is effective in the treatment of refractory rheumatoid arthritis (RA). Its use by practitioners has become commonplace, even though it is not yet approved by the Food and Drug Administration for this use. One might assume, therefore, that there is a general understanding, among pr
β¦ LIBER β¦
Is methotrexate oncogenic in patientswith rheumatoid arthritis?
β Scribed by Joel M. Kremer
- Book ID
- 114098580
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 228 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0049-0172
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Methotrexate in rheumatoid arthritis
β
Daniel E. Furst; Joel M. Kremer
π
Article
π
1988
π
John Wiley and Sons
π
English
β 1007 KB
Methotrexate in rheumatoid arthritis
β
Weinblatt, Michael E.; Kremer, Joel M.
π
Article
π
1988
π
Elsevier Science
π
English
β 301 KB
Methotrexate in Rheumatoid Arthritis
β
Tugwell, Peter
π
Article
π
1990
π
American Medical Association
π
English
β 579 KB
Methotrexate Chronotherapy is Effective
β
To, Hideto; Yoshimatsu, Hiromichi; Tomonari, Mari; Ida, Hiroaki; Tsurumoto, Tosh
π
Article
π
2011
π
Informa plc
π
English
β 355 KB
Methotrexate in refractory rheumatoid ar
β
A. M. Th. Boerbooms; M. E. C. Jeurissen; A. A. A. Westgeest; H. Theunisse; L. B.
π
Article
π
1988
π
Springer
π
English
β 494 KB
Methotrexate in juvenile rheumatoid arth
β
F. Albertioni; O. Beck; C. Peterson; B. FlatΓΈ; O. Vinje; S. Eksborg; P. Seideman
π
Article
π
1995
π
Springer
π
English
β 490 KB
Children with juvenile rheumatoid arthritis (JRA) have been reported to require higher doses (per kg body weight) of methotrexate (MTX) than adults with rheumatoid arthritis to control their disease. The purpose of the present study was to characterise the plasma pharmacokinetics of MTX and its majo